Page last updated: 2024-09-04

n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and sk&f 77434

n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with sk&f 77434 in 1 studies

Compound Research Comparison

Studies
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Trials
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Recent Studies (post-2010)
(n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide)
Studies
(sk&f 77434)
Trials
(sk&f 77434)
Recent Studies (post-2010) (sk&f 77434)
14003105

Protein Interaction Comparison

ProteinTaxonomyn-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide (IC50)sk&f 77434 (IC50)
DRattus norvegicus (Norway rat)0.0197
D(2) dopamine receptorRattus norvegicus (Norway rat)2.425

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, J; Tidey, JW1

Other Studies

1 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and sk&f 77434

ArticleYear
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines; Catalepsy; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Methamphetamine; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri

1998